TY - JOUR
T1 - The Role of Telehealth During the COVID-19 Pandemic Across the Interdisciplinary Cancer Team
T2 - Implications for Practice
AU - Paterson, Catherine
AU - Bacon, Rachel
AU - Dwyer, Rebecca
AU - Morrison, Kittani S.
AU - Toohey, Kellie
AU - O'Dea, Amy
AU - Slade, James
AU - Mortazavi, Reza
AU - Roberts, Cara
AU - Pranavan, Ganes
AU - Cooney, Corrina
AU - Nahon, Irmina
AU - Hayes, Sandra C.
PY - 2020/12
Y1 - 2020/12
N2 - Objective: This literature review aims to explore the role of telehealth during the COVID-19 pandemic across the interdisciplinary cancer care team. Data Sources: Electronic databases including CINAHL, MEDLINE, PsychINFO, Scopus, and gray literature were searched using Google Scholar up until September 2020. Conclusion: Although the safe and effective delivery of cancer care via telehealth requires education and training for health care professionals and patients, telehealth has provided a timely solution to the barriers caused by the COVID-19 pandemic on the delivery of interdisciplinary cancer services. Globally, evidence has shown that telehealth in cancer care can leverage an innovative response during the COVID-19 pandemic but may provide a long-lasting solution to enable patients to be treated appropriately in their home environment. Telehealth reduces the travel burden on patients for consultation, affords a timely solution to discuss distressing side effects, initiate interventions, and enable possible treatment additions and/or changes. Implications for Nursing Practice: Global public health disasters pose significant and unique challenges to the provision of necessary services for people affected by cancer. Oncology nurses can provide a central contribution in the delivery of telehealth through transformational leadership across all domains and settings in cancer care. Oncology nurses provide the “hub of cancer care” safely embedded in the interdisciplinary team. Telehealth provides a solution to the current global health crisis but could also benefit the future provision of services and broad reach clinical trials.
AB - Objective: This literature review aims to explore the role of telehealth during the COVID-19 pandemic across the interdisciplinary cancer care team. Data Sources: Electronic databases including CINAHL, MEDLINE, PsychINFO, Scopus, and gray literature were searched using Google Scholar up until September 2020. Conclusion: Although the safe and effective delivery of cancer care via telehealth requires education and training for health care professionals and patients, telehealth has provided a timely solution to the barriers caused by the COVID-19 pandemic on the delivery of interdisciplinary cancer services. Globally, evidence has shown that telehealth in cancer care can leverage an innovative response during the COVID-19 pandemic but may provide a long-lasting solution to enable patients to be treated appropriately in their home environment. Telehealth reduces the travel burden on patients for consultation, affords a timely solution to discuss distressing side effects, initiate interventions, and enable possible treatment additions and/or changes. Implications for Nursing Practice: Global public health disasters pose significant and unique challenges to the provision of necessary services for people affected by cancer. Oncology nurses can provide a central contribution in the delivery of telehealth through transformational leadership across all domains and settings in cancer care. Oncology nurses provide the “hub of cancer care” safely embedded in the interdisciplinary team. Telehealth provides a solution to the current global health crisis but could also benefit the future provision of services and broad reach clinical trials.
KW - Cancer care
KW - Coronavirus
KW - COVID-19
KW - Disaster management
KW - Interdisciplinary
KW - Nursing
KW - Telehealth
UR - http://www.scopus.com/inward/record.url?scp=85097197552&partnerID=8YFLogxK
U2 - 10.1016/j.soncn.2020.151090
DO - 10.1016/j.soncn.2020.151090
M3 - Review article
C2 - 33218886
AN - SCOPUS:85097197552
SN - 0749-2081
VL - 36
JO - Seminars in Oncology Nursing
JF - Seminars in Oncology Nursing
IS - 6
M1 - 151090
ER -